Please use this identifier to cite or link to this item:
Title: Survival of patients ≥70 years with advanced chronic kidney disease: Dialysis vs. conservative care.
Other Titles: Supervivencia de pacientes de edad avanzada (≥70 años) con enfermedad crónica estadios 4-5: diálisis vs tratamiento conservador.
Authors: Martínez Echevers, Yeleine
Toapanta Gaibor, Néstor Gabriel
Nava Pérez, Nathasha
Barbosa Martin, Francisco
Montes Delgado, Rafael
Guerrero Riscos, María Ángeles
Keywords: Advanced chronic kidney disease;Ancianos;Conservative care;Elderly;Enfermedad renal crónica avanzada;Frail patient;Paciente frágil;Supervivencia;Survival;Tratamiento conservador
metadata.dc.subject.mesh: Age Factors
Aged, 80 and over
Conservative Treatment
Diabetes Mellitus
Kaplan-Meier Estimate
Linear Models
Myocardial Ischemia
Proportional Hazards Models
Renal Dialysis
Renal Insufficiency, Chronic
Retrospective Studies
Issue Date: 19-Apr-2016
Abstract: The number of elderly patients with advanced chronic kidney disease (ACKD) has increased in recent years, and the best therapeutic approach has not been determined due to a lack of evidence. To observe the progression of elderly patients with ACKD (stages 4 and 5) and to compare the survival of stage 5 CKD patients with and without dialysis treatment. All patients ≥70 years who began ACKD follow-up from 01/01/2007 to 31/12/2008 were included, and their progression was observed until 31/12/2013. Demographic data, the Charlson comorbidity index, history of ischaemic heart disease (IHD) and diabetes mellitus (DM) were assessed. A total of 314 patients ≥70 years with stages 4 and 5 CKD were studied. Of these patients, 162 patients had stage 5 CKD at the beginning of follow-up or progressed to stage 5 during the study, and 69 of these patients were treated with dialysis. In the stage 5 group: median age was 77 years (74-81); 48% had IHD; 50% had DM, Charlson 7 (6-9). Kaplan-Meier survival analysis: ≥70 years (93 vs. 69 patients with dialysis, log rank: 15 P Our study shows that dialysis treatment improves survival, although this benefit is lost in patients ≥80 years.
metadata.dc.identifier.doi: 10.1016/j.nefro.2015.11.006
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons